Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Anchor Therapeutics Inc.
DescriptionPepducin-based allosteric agonist against CXC chemokine receptor 4 (CXCR4; NPY3R)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today